Table 1. Baseline characteristics of the study cohort.
Variable | Clade A1 (n = 150) | Clade D (n = 54) | P value |
Mean age, years (median, IQR) | 35 (30–39) | 32 (27–38) | 0.32 |
Kenyan | 25.5% | 14.8% | 0.13 |
Follow-up, days (median, IQR) | 2,438 (1,309–3,824) | 2,057 (972–3,230) | 0.159 |
CD4 count at baseline (median, IQR) | 576 (453–740) | 516 (413–689) | 0.133 |
No. of CD4 counts (median, IQR) | 11 (6–16) | 8.5 (4–15) | 0.077 |
Protective HLA | 29.1% | 18.9% | 0.20 |
% with VL data | 48.7% | 35.2% | 0.11 |
Average log10 copies/ml (VL; median, IQR) | 3.74 (3.02–4.48) | 3.95 (3.53–4.91) | 0.186 |